University of Oxford researchers have developed a technology that allows devices such as mobile phones and cameras to both charge and transmit data without cables. Current applications target smaller, low power devices. However, employed on a larger scale, this technology might eliminate the need for power and data cables altogether.
A spin-out from the University of Oxford, Oxford Vacmedix, will commercialise a new technology with the potential to reduce the cost of vaccine development significantly and increase the effectiveness of vaccines in providing immunity against both infectious diseases and cancer. The technology makes use of techniques that have already produced effective vaccines under laboratory conditions.
The latest spin-out from the University of Oxford, Run3D Ltd, offers Europe’s first computerised three-dimensional assessment for preventing the types of overuse injuries that affect 50% of runners. Run3D’s service uses 3D motion analysis checked against the world’s largest biomechanical database to identify any abnormal patterns in a runner’s gait. These abnormal patterns are often the root cause of an injury which once corrected can prevent any recurrence.
Oxford Catalysts was spun-out to produce catalysts for the generation of clean fuels by Isis in 2005 and is now valued at approx. £130m.
The 2012 UK Life Science Start-up report is prepared from seven years of data on the creation and funding of life science companies. The authors observe that, “Academic spin-out activity has become more and more focused in a few, leading universities as many increasingly lack confidence in the spin-out model of technology transfer or the resources to implement it effectively”.
Cleantech investment specialists MTI Partners has announced the completion of a £2 million investment round in Oxford Photovoltaics Limited (OPV), a spin-out company commercialising solid-state dye sensitised solar cells for the Building Integrated Photovoltaic (BIPV) sector.
Oxford scientists have developed a new technique that can spot early liver disease. At present, liver disease can only be accurately determined by an invasive biopsy, as there are no tell-tale symptoms. The new scan uses standard MRI technology and costs half as much as a biopsy.
Oxford University Innovation, the technology transfer company of the University of Oxford, will be working with CEDA for the first time to deliver an Innovation Management Masterclass, aimed at delivering an in-depth understanding of key innovation management principles, tools and management techniques.
SmartEatOut is a group dining solution bringing together people and restaurants. By signing up for free people can join Smart-groups and meet others around the table or simply book a table for a private celebration with their friends.
Oxford’s latest startup gives us an outlet for British uncomplaining reserve. goKomplain lets you to voice your discontent and allows the public to offer solutions. Coming out of Oxford University Innovation, the new company already boasts providing solutions when none seemed possible.
